Companies: 10,638     total market cap: โ‚ฌ116.357 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Exelixis
EXEL
#1694
Rank
โ‚ฌ10.25 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
38,10ย โ‚ฌ
Share price
-0.02%
Change (1 day)
11.91%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.15 Billion

According to Exelixis's latest financial reports the company's total debt is โ‚ฌ0.15 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Exelixis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ0.18 B6.72%
2023-12-31โ‚ฌ0.17 B-3.08%
2022-12-31โ‚ฌ0.17 B291.59%
2021-12-31โ‚ฌ45.27 M13.44%
2020-12-31โ‚ฌ39.9 M-6.88%
2019-12-31โ‚ฌ42.85 M228.7%
2018-12-31โ‚ฌ13.03 M4.73%
2017-12-31โ‚ฌ12.44 M-93.08%
2016-12-31โ‚ฌ0.17 B-52.96%
2015-12-31โ‚ฌ0.38 B30.23%
2014-12-31โ‚ฌ0.29 B16.73%
2013-12-31โ‚ฌ0.25 B-0.94%
2012-12-31โ‚ฌ0.25 B81.59%
2011-12-31โ‚ฌ0.13 B-10.81%
2010-12-31โ‚ฌ0.15 B182.02%
2009-12-31โ‚ฌ55.57 M-33.98%
2008-12-31โ‚ฌ84.17 M1.15%
2007-12-31โ‚ฌ83.22 M-9.73%
2006-12-31โ‚ฌ92.19 M-26.63%
2005-12-31โ‚ฌ0.12 B15.67%
2004-12-31โ‚ฌ0.10 B23.12%
2003-12-31โ‚ฌ88.23 M24.75%
2002-12-31โ‚ฌ70.72 M27.62%
2001-12-31โ‚ฌ55.41 M249.21%
2000-12-31โ‚ฌ15.86 M20.07%
1999-12-31โ‚ฌ13.21 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
GlaxoSmithKline
GSK
โ‚ฌ20.49 B 13,422.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚ฌ21.92 B 14,368.36%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ35.53 B 23,346.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ43.83 B 28,824.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ46.88 B 30,833.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 25,851.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.26 B 34,382.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ1.69 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚ฌ33.22 M-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com